Electrocardiographic predictors of arrhythmic death

Annals of Noninvasive Electrocardiology

Volumn 11, Issue 4, 2006, Pages 327-337

  McLaughlin, Michael G ^a   Zimetbaum, Peter J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY MONITORING; BRUGADA SYNDROME; CARDIOVASCULAR DISEASE; DEFIBRILLATOR; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; EPIDEMIOLOGICAL DATA; FALLOT TETRALOGY; HEART ARRHYTHMIA; HEART FAILURE; HEART RATE VARIABILITY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LONG QT SYNDROME; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SUDDEN DEATH; TREADMILL; TREATMENT INDICATION;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; HEART RATE; HUMANS; PREDICTIVE VALUE OF TESTS;

EID: 33749824648     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2006.00125.x     Document Type: Review

References (58)

1. Olshausen KV, Witt T, Pop T, et al. Sudden cardiac death while wearing a Holter monitor. Am J Cardiol 1991;67:381-386.
2. Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989;117:151-159.
3. Zheng ZJ, Croft JB, Giles WH, et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-2163.
4. Centers for Disease Control and Prevention (CDC). State-specific mortality from sudden cardiac death - United States, 1999. Morb Mortal Wkly Rep 2002;51:123-126.
5. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-788.
6. Moss AJ, Hall WJ, Cannom DS, et al., for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disase at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
7. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-1890.
8. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
9. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
10. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
11. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000;21:2071-2078.
12. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
13. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: Structure, function, and time-dependence of risk. Circulation 1992;85(Suppl. 1):I2-I10.
14. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: Expanding indications and technologies. JAMA 2006;295:809-818.
15. Elhendy A, Hammill SC, Mahoney DW, et al. Relation of QRS duration on the surface 12-lead electrocardiogram with mortality in patients with known or suspected coronary artery disease. Am J Cardiol 2005;96:1082-1088.
16. Freedman R, Alderman E, Sheffield L, et al. Bundle branch block in patients with chronic coronary artery disease: Angiographic correlates and prognostic significance. J Am Coll Cardiol 1987;10:73-80.
17. Zimetbaum PJ, Buxton AE, Batsford W, et al. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation 2004;110:766-769.
18. Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2005;350:2151-2158.
19. Buxton AE, Sweeney MO, Wathen MS, et al. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. J Am Coll Cardiol 2005;46:310-316.
20. Diaz ME, O'Neill SC, Eisner DA. Sarcoplasmic reticulum calcium content fluctuation is key to cardiac alternans. Circ Res 2004;94:650-656.
21. Pastore JM, Girouard SD, Laurita KR, et al. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 1999;99:1385-1394.
22. Herring H. Experimentelle Studien an Saugentieren uber das Electrocardiogram. Z Exper Med 1909;7:363.
23. Rosenbaum DS, Jackson LE, Smith JM, et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994;330:235-241.
24. Gold MR, Bloomfield DM, Anderson KP, et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 2000;36:2247-2253.
25. Ikeda T, Sakata T, Takami M, et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 2000;35:722-730.
26. Estes NA3rd, Michaud G, Zipes DP, et al. Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. Am J Cardiol 1997;80:1314-1318.
27. Hohnloser SH, Klingenheben T, Li YG, et al. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: Prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 1998;9:1258-1268.
28. Gehi AK, Stein RH, Metz LD, et al. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: Ameta-analysis. J AmColl Cardiol 2005;46:75-82.
29. Bloomfield DM, Steinman RC, Namerow PB, et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 2004;110:1885-1889.
30. Bloomfield DM, Bigger JT, Steinman RC, et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006;47:456-463.
31. Bigger JT. Prevalence, characteristics and significance of ventricular tachycardia detected by 24 hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am J Cardiol 1986;58:1151-1160.
32. Mukharji J, Rude RE, Poole WK, et al. Risk factors for sudden death after acute myocardial infarction: Two year follow-up. Am J Cardiol 1984;54:31-36.
33. Senges JC, Becker R, Schreiner KD, et al. Variability of Holter electrocardiographic findings in patients fulfilling the noninvasive MADIT criteria. Multicenter Automatic Defibrillator Implantation Trial. Pacing Clin Electrophysiol 2002;25:183-190.
34. Hohnloser SH, Klingenheben T, Zabel M, et al. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1999;33:1895-1902.
35. Maggioni AP, Zuanetti G, Franzosi MG, et al. Prevalence and prognostic significance of ventricular arrhythmia after acute myocardial infarction after acute myocardial infarction in the thrombolytic era. GISSI-2 results. Circulation 1993;87:312-322.
36. Maron BJ, Savage DD, Wolfson JK, et al. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study. Am J Cardiol 1981;48:252-257.
37. Adabag AS, Casey SA, Kuskowski MA, et al. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;45:697-704.
38. Singh SN, Fisher SG, Carson PE, et al. and the Department of Veteran Affairs CHF-STAT Investigators. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. J Am Coll Cardiol 1998;32:942-947.
39. Larsen L, Markham J, Haffajee CI. Sudden death in idiopathic dilated cardiomyopathy: Role of ventricular arrhythmias. Pacing Clin Electrophysiol 1993;16:1051-1059.
40. Kligfield P, Levy D, Devereux RB, et al. Arrhythmias and sudden death in mitral valve prolapse. Am Heart J 1987;113:1298-1307.
41. Kligfield P, Hochreiter C, Niles N, et al. Relation of sudden death in pure mitral regurgitation, with and without mitral valve prolapse, to repetitive ventricular arrhythmias and right and left ventricular ejection fractions. Am J Cardiol 1987;60:397-399.
42. Wolfe R. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect. Results of 24-hour ECG monitoring. Circulation 1993;87:I89-I101.
43. Kleiger RE, Miller JP, Bigger JT Jr, et al., and the Multicenter Postinfarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-262.
44. Bigger JT Jr, Fleiss JL, Steinman RC, et al. Correlation among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol 1992;69:891-898.
45. Singh N, Mironov D, Armstrong PW, et al. for the GUSTO ECG Substudy Investigators. Heart rate variability assessment early after acute myocardial infarction: Pathophysiologic and prognostic correlates. Circulation 1996;93:1388-1395.
46. Zuanetti G, Neilson JMM, Latini R, et al on behalf of the GISSI-2 Investigators. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Circulation 1996;94:432-436.
47. La Rovere MT, Bigger JT Jr, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998;351:478-484.
48. Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991;18:687-697.
49. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-2488.
50. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation 1998;98:1510-1516.
51. Breithardt G, Borggrefe M, Karbenn U, et al. Prevalence of late potentials in patients with and without ventricular tachycardia: Correlation with angiographic findings. Am J Cardiol 1983;49:1932-1937.
52. Gomes JA, Cain ME, Buxton AE, et al. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 2001;104:436-441.
53. Bauer A, Guzik P, Barthel P, et al. Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J 2005;26:755-761.
54. Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998;339:364-369.
55. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92:2929-2934.
56. Moss AJ. T-wave patterns associated with the hereditary long QT syndrome. Card Electrophysiol Rev 2002;6:311-315.
57. Gatzoulis MA, Till JA, Somerville J, et al. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation 1995;92:231-237.
58. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: A multicentre study. Lancet 2000;356:975-981.